Medical Care Technologies Inc.
MDCE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2013 | |
|---|---|---|---|---|
| Revenue | $656 | $732 | $3,470 | $0 |
| % Growth | -10.3% | -78.9% | – | – |
| Cost of Goods Sold | $335 | $789 | $2,139 | $0 |
| Gross Profit | $322 | -$57 | $1,330 | $0 |
| % Margin | 49% | -7.8% | 38.3% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $324 | $231 | $0 |
| SG&A Expenses | $169 | $324 | $231 | $4,334 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $169 | $324 | $231 | $4,334 |
| Operating Income | $153 | -$381 | $1,099 | -$4,334 |
| % Margin | 23.3% | -52.1% | 31.7% | – |
| Other Income/Exp. Net | -$3 | -$6 | -$0 | -$25 |
| Pre-Tax Income | $150 | -$388 | $1,099 | -$4,359 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $150 | -$388 | $1,099 | -$4,359 |
| % Margin | 22.9% | -52.9% | 31.7% | – |
| EPS | 0 | -0 | 0 | -4.83 |
| % Growth | 100% | -133.3% | 100% | – |
| EPS Diluted | 0 | -0 | 0 | -4.83 |
| Weighted Avg Shares Out | 3,309,575 | 3,229,217 | 3,209,575 | 902 |
| Weighted Avg Shares Out Dil | 3,309,575 | 3,209,575 | 3,209,575 | 902 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $6 | $0 | $25 |
| Depreciation & Amortization | $0 | $381 | $228 | $0 |
| EBITDA | $153 | $0 | $1,328 | -$4,334 |
| % Margin | 23.3% | 0% | 38.3% | – |